LLY and NOVOB Related Headlines
Go Back- CVS Adds Lilly's Zepbound To Preferred Drug List In Reversal
- The Next Generation of the GLP-1 Revolution Is Already Underway
- Biotech’s Next Wave May Already be in Motion
- Novo To Cut Ozempic, Wegovy's US List Prices By Up To 50% - WSJ
- GLP-1s Should Be First Line To Prevent Heart Disease, Acc Says - Bloomberg
LLY and NOVOB Related Press Releases
Go Back- The Next Generation of the GLP-1 Revolution Is Already Underway
- Biotech’s Next Wave May Already be in Motion
